Application 021360
- Type
- NDA
- Sponsor
- BRISTOL MYERS SQUIBB
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUSTIVA | EFAVIRENZ | TABLET;ORAL | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | SUSTIVA | EFAVIRENZ | TABLET;ORAL | 600MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021360-001 | SUSTIVA | EFAVIRENZ | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | |
| N021360-002 | SUSTIVA | EFAVIRENZ | 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021360-002 | SUSTIVA | 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021360-002 | SUSTIVA | 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021360-002 | SUSTIVA | 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021360-002 | SUSTIVA | 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | RLD | 2002-02-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | AB | RLD, RS | 2002-02-01 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | AB | RLD, RS | 2002-02-01 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | AB | RLD, RS | 2002-02-01 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2002-02-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | AB | RLD, RS | 2002-02-01 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021360-001 | SUSTIVA | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2002-02-01 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021360-002 | SUSTIVA | 600MG | TABLET / ORAL | AB | RLD, RS | 2002-02-01 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021360-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021360-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021360-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021360-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021360-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021360-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021360-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021360-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021360-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021360-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021360-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021360-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021360-002 | AB | 1 | ea99ee380514… |
| 2022-09-29 23:25 UTC | 2022-09 | N021360-002 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021360-002 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Efavirenz | EFAVIRENZ | Macleods Pharmaceuticals Limited | 13ca3456-e5bf-4bb1-af95-b1378658a358 | 2024-06-28 | Warnings, Adverse reactions | EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Cipla USA Inc. | 92603fa5-7a2c-4bfb-9a70-aadb4fba952c | 2024-03-31 | Warnings, Adverse reactions | EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Aurobindo Pharma Limited | 4c57ad7f-321a-46c8-851a-c895466eb8e1 | 2023-12-29 | Warnings, Adverse reactions | EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Aurobindo Pharma Limited | c5eedb5d-4cab-4056-a14a-ffdf67701355 | 2023-12-29 | Warnings, Adverse reactions | EFAVIRENZ |
| Efavirenz | EFAVIRENZ | Camber Pharmaceuticals, Inc. | 6d625901-fef2-4c93-9619-f8991d65413d | 2023-05-15 | Warnings, Adverse reactions | EFAVIRENZ |
| EFAVIRENZ | EFAVIRENZ | XLCare Pharmaceuticals Inc. | 966b815d-1d78-4b54-8f00-c5a0b67c78be | 2023-01-12 | Warnings, Adverse reactions | EFAVIRENZ |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 0056-0510 | SUSTIVA | efavirenz | Bristol-Myers Squibb Pharma Company | NDA | Current |
| 70518-0482 | SUSTIVA | efavirenz | REMEDYREPACK INC. | NDA | Current |
| 70518-0482 | SUSTIVA | efavirenz | REMEDYREPACK INC. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76552 | SUPPL | 2023-11-13 |
| 76544 | SUPPL | 2023-11-09 |
| 60730 | SUPPL | 2019-10-30 |
| 60712 | SUPPL | 2019-10-30 |
| 50030 | SUPPL | 2017-10-12 |
| 50004 | SUPPL | 2017-10-11 |
| 47053 | SUPPL | 2017-01-31 |
| 47060 | SUPPL | 2017-01-30 |
| 45624 | SUPPL | 2016-10-17 |
| 45212 | SUPPL | 2016-08-31 |
| 45193 | SUPPL | 2016-08-31 |
| 36759 | SUPPL | 2016-04-01 |
| 5172 | SUPPL | 2016-04-01 |
| 15299 | SUPPL | 2015-04-02 |
| 5171 | SUPPL | 2015-04-01 |
| 36758 | SUPPL | 2014-05-28 |
| 27594 | SUPPL | 2014-05-27 |
| 5170 | SUPPL | 2013-05-07 |
| 15298 | SUPPL | 2013-05-03 |
| 27593 | SUPPL | 2012-08-15 |
| 15297 | SUPPL | 2012-08-15 |
| 15296 | SUPPL | 2012-06-26 |
| 5169 | SUPPL | 2012-06-26 |
| 5168 | SUPPL | 2011-12-21 |
| 36757 | SUPPL | 2011-12-19 |
| 5167 | SUPPL | 2011-09-29 |
| 36756 | SUPPL | 2011-09-27 |
| 5166 | SUPPL | 2010-12-03 |
| 15295 | SUPPL | 2010-11-29 |
| 5165 | SUPPL | 2010-04-05 |
| 15294 | SUPPL | 2010-04-04 |
| 27592 | SUPPL | 2009-11-10 |
| 15293 | SUPPL | 2009-10-01 |
| 15292 | SUPPL | 2009-04-23 |
| 5164 | SUPPL | 2009-03-12 |
| 36755 | SUPPL | 2008-08-26 |
| 27591 | SUPPL | 2008-08-20 |
| 42118 | SUPPL | 2007-07-20 |
| 21618 | SUPPL | 2007-07-20 |
| 27590 | SUPPL | 2007-02-05 |
| 15291 | SUPPL | 2007-02-05 |
| 36754 | SUPPL | 2007-02-02 |
| 5163 | SUPPL | 2007-02-02 |
| 36753 | SUPPL | 2005-04-28 |
| 5162 | SUPPL | 2005-04-28 |
| 15290 | SUPPL | 2004-11-01 |
| 27589 | SUPPL | 2004-10-29 |
| 27588 | SUPPL | 2004-08-25 |
| 15289 | SUPPL | 2004-08-25 |
| 36752 | SUPPL | 2003-12-01 |
| 27587 | SUPPL | 2003-11-26 |
| 27586 | SUPPL | 2003-06-22 |
| 27585 | SUPPL | 2003-06-22 |
| 15288 | SUPPL | 2003-06-22 |
| 15287 | SUPPL | 2003-06-22 |
| 5161 | SUPPL | 2002-09-20 |
| 21617 | ORIG | 2002-05-15 |
| 36751 | ORIG | 2002-02-01 |
| 27584 | ORIG | 2002-02-01 |